Systemic Retinoids for Generalized Verrucosis Due to Congenital Immunodeficiency: Case Reports and Review of the Literature-Reference-Cited by-同舟云学术

Systemic Retinoids for Generalized Verrucosis Due to Congenital Immunodeficiency: Case Reports and Review of the Literature

Published:2023-03-22 Issue:3 Volume:14 Page:769
ISSN:2073-4425
Container-title:Genes
language:en
Short-container-title:Genes

Author:

Kosumi Hideyuki¹^ORCID,Natsuga Ken²^ORCID,Yanagi Teruki²^ORCID,Ujiie Hideyuki²

Affiliation:

1. Department of Dermatology, Hokkaido University Hospital, Sapporo 060-8638, Japan

2. Department of Dermatology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo 060-8638, Japan

Abstract

Generalized verrucosis (GV) is a group of immunodeficiency disorders accompanied by widespread human papillomavirus infection. We revisit two cases of GV due to congenital interleukin-7 deficiency successfully treated with systemic retinoids. We also present a review of the literature on the use of systemic retinoids to treat GV. Our review suggests that systemic retinoids are a safe and effective option for managing recalcitrant wart lesions in cases of GV.

Publisher

MDPI AG

Subject

Genetics (clinical),Genetics

Link

https://www.mdpi.com/2073-4425/14/3/769/pdf

Reference33 articles.

1. Papillomavirus infections—A major cause of human cancers;Biochim. Biophys. Acta,1996

2. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments;Bernard;Virology,2010

3. Clinicoepidemiological Study of Different Types of Warts;Ghadgepatil;Dermatol. Res. Pract.,2016

4. Regression of warts. An immunological study;Johansson;Lancet,1975

5. Role of cell-mediated immunity in spontaneous regression of plane warts;Rogozinski;Int. J. Dermatol.,1988